Design of the INTEGRATE study: Effectiveness and cost-effectiveness of a cardiometabolic risk assessment and treatment program integrated in primary care

BMC Family Practice

Volumn 15, Issue 1, 2014, Pages

  Badenbroek, Ilse F ^a,b   Stol, Daphne M ^a,b   Nielen, Marcus Mj ^a   Hollander, Monika ^b   Kraaijenhagen, Roderik A ^c   De Wit, G Ardine ^b,d   Schellevis, François G ^a,e   De Wit, Niek J ^b  

^a NETHERLANDS INSTITUTE FOR HEALTH SERVICES RESEARCH   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c NDDO Institute for Prevention and Early Diagnostics NIPED   (Netherlands)

^d NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^e VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

(Primary) screening; Cardiometabolic disease; Economic evaluation; Effectiveness; Family practice; Non participation; Prevention; Primary care; RCT

Indexed keywords

AGED; CARDIOVASCULAR DISEASES; COST BENEFIT ANALYSIS; DIABETES MELLITUS; ECONOMICS; FEMALE; HUMAN; KIDNEY FAILURE, CHRONIC; MALE; METHODOLOGY; MIDDLE AGED; PRIMARY HEALTH CARE; PRIMARY PREVENTION; PROCEDURES; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK ASSESSMENT;

AGED; CARDIOVASCULAR DISEASES; COST-BENEFIT ANALYSIS; DIABETES MELLITUS; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PRIMARY HEALTH CARE; PRIMARY PREVENTION; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESEARCH DESIGN; RISK ASSESSMENT;

EID: 84901014871     PISSN: None     EISSN: 14712296     Source Type: Journal    
DOI: 10.1186/1471-2296-15-90     Document Type: Article

References (39)

1. Van der Lucht F, Polder J, Van Gezond Naar Beter. Volksgezondheid Toekomst Verkenning 2010 Bilthoven: Rijksinstituut voor Volksgezondheid en Milieu 2010
2. Prevalence, numerical estimates, and projections. King H, Aubert R, Herman W, Diabetes Care 2000 21 1414 1431
3. Global burden of cardiovascular diseases: part I: general considerations, the epidemiologic transition, risk factors, and impact of urbanization. Yusuf S, Reddy S, Ounpuu S, Anand S, Circulation 2001 104 2746 2753 10.1161/hc4601.099487 11723030 (Pubitemid 33108145)
4. The epidemiology of obesity: the size of the problem. James WPT, J Intern Med 2008 263 336 352 10.1111/j.1365-2796.2008.01922.x 18312311 (Pubitemid 351342683)
5. The usefulness of a free self-test for screening albuminuria in the general population: a cross-sectional survey. Nielen MM, Schellevis FG, Verheij R, BMC Public Health 2009 9 381 10.1186/1471-2458-9-381 19818129
6. De Jongh D, van Dijk L, Schellevis F, Vroege Opsporing En Behandeling van Mensen Met Risicofactoren Voor Hart- En Vaatziekten. Evaluatie van Initiatieven Utrecht: NIVEL 2007
7. Preventie in de huisartsenpraktijk: kom in beweging! Drenthen A, Assendelft W, van der Velden J, Huisarts Wet 2008 51 38 41 10.1007/BF03086632 (Pubitemid 351218570)
8. Primary prevention of cardio-metabolic diseases in general practice: a Dutch survey of attitudes and working methods of general practitioners. Nielen MMJ, Assendelft WJJ, Drenthen AJM, Van Den Hombergh P, Van Dis I, Schellevis FG, Eur J Gen Prac 2010 16 139 142 10.3109/13814788.2010.501372
9. Prevalentie van Leefstijl- en Risicofactoren Voor Hart- en Vaatziekten in Nederland Onder Nederlandse Werknemers. Peek N, Niessen MAJ, Kraaijenhagen RA, Hart- en Vaatziekten in Nederland 2010 Cijfers Over Leefstijl- en Risicofactoren, Ziekte en Sterfte Den Haag: Nederlandse Hartstichting 2010
10. Effects on cardiovascular disease risk of a web-based health risk assessment with tailored health advice: a follow-up study. Colkesen EB, Ferket BS, Tijssen JGP, Kraaijenhagen R, van Kalken CK, Peters RJG, Vasc Health Risk Manag 2011 7 67 74 21415919
11. Participation in a workplace web-based health risk assessment program. Colkesen EB, Kraaijenhagen R, Frings-Dresen MHW, Sluiter JK, van Kalken CK, Tijssen JGP, Peters RJG, Occup Med (Lond) 2011 61 586 589 10.1093/occmed/kqr122 21891778
12. Initiation of health-behaviour change among employees participating in a web-based health risk assessment with tailored feedback. Colkesen EB, Niessen MA, Peek N, Vosbergen S, Kraaijenhagen R a, van Kalken CK, Tijssen JG, Peters RJ, J Occup Med Toxicol 2011 6 5 10.1186/1745-6673-6-5 21388524
13. NHG-standaard Het PreventieConsult module cardiometabool NHG-standaard. Dekker J, Alssema M, Janssen P, Van der Paardt M, Festen C, van Oosterhout M, van Dijk J, van der Weijden T, Gansevoort R, Dasselaar J, van Zoest F, Drenthen T, Walma E, Goudswaard A, Huisarts Wet 2011 54 138 155
14. Nielen M, Schellevis F, Evaluatie Pilot PreventieConsult Cardiometabool Risico Utrecht: NIVEL 2010
15. Eerste ervaringen met het PreventieConsult cardiometabool risico. Nielen M, Van Der MV, Assendelft P, Schellevis F, Huisarts Wet 2011 54 414 419 10.1007/s12445-011-0199-4
16. PreventieConsult in praktijk: een pilot. Klomp M, Meulepas M, Anema B, Harms L, Med Contact 2011 11 659 661
17. Cardiometabolic prevention consultation in the Netherlands: screening uptake and detection of cardiometabolic risk factors and diseases-a pilot study. Van der Meer V, Nielen MM, Drenthen AJ, Van Vliet M, Assendelft WJ, Schellevis FG, BMC Fam Pract 2013 14 29 10.1186/1471-2296-14-29 23442805
18. Cardiometabole risicofactoren opgespoord met preventieconsult. Van de Kerkhof RM, Godefrooij MB, Wouda PJ, Vening RA, Dinant G, Spigt MG, Ned Tijdschr Geneeskd 2010 154 1860 21040602
19. Wyers DCE, Evers P dr, SMAA D mr, Ruwaard P dr, Faculty of Health, Medicine and Life Sciences Ex-ante Kosteneffectiviteitsanalyse van Het PreventieConsult Cardiometabool Risico Maastricht: Maastricht University Faculty of Health, Medicine and Life Sciences 2013
20. Koopmans B, Korevaar J, Nielen M, Verhaak P, de Jong J, van Dijk L, Noordman J, Veenhof C, Schellevis F, Preventie Kan Effectiever! Deelnamebereidheid En Deelnametrouw Aan Preventieprogramma's in de Zorg Utrecht: NIVEL 2012
21. Non-participation in population-based disease prevention programs in general practice. Koopmans B, Nielen M, Schellevis F, Korevaar J, BMC Public Health 2012 12 856 10.1186/1471-2458-12-856 23046688
22. Cross-sectional review of the response and treatment uptake from the NHS Health Checks programme in Stoke on Trent. Cochrane T, Gidlow CJ, Kumar J, Mawby Y, Iqbal Z, Chambers RM, J Public Health (Oxf) 2013 35 92 98 10.1093/pubmed/fds088 23104892
23. Lamberts H, Wood M, International Classification of Primary Care Oxford: Oxford University Press 1987
24. Het PreventieConsult Cardiometabool risico. Nielen M, Davids R, De BD, Huisarts Wet 2011 54 121 10.1007/s12445-011-0062-7
25. The diabetes risk score: a practical tool to predict type 2 diabetes risk. Lindström J, Tuomilehto J, Diabetes Care 2003 26 725 731 10.2337/diacare.26.3.725 12610029 (Pubitemid 36929335)
26. One risk assessment tool for cardiovascular disease, type 2 diabetes, and chronic kidney disease. Alssema M, Newson RS, Bakker SJL, Stehouwer CD a, Heymans MW, Nijpels G, Hillege HL, Hofman A, Witteman JCM, Gansevoort RT, Dekker JM, Diabetes Care 2012 35 741 748 10.2337/dc11-1417 22338109
27. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Conroy R, Pyörälä K, Fitzgerald A, Sans S, Menotti A, de Backer G, de Bacquer D, Ducimetière P, Jousilahti P, Keil U, Njølstad I, Oganov R, Thomsen T, Tunstall-Pedoe H, Tverdal A, Wedel H, Whincup P, Wilhelmsen L, Graham Group. S project, Eur Heart J 2003 24 987 1003 10.1016/S0195-668X(03)00114-3 12788299 (Pubitemid 36712275)
28. Dynamic effects of smoking cessation on disease incidence, mortality and quality of life: The role of time since cessation. Hoogenveen RT, van Baal PH, Boshuizen HC, Feenstra TL, Cost Eff Resour Alloc 2008 6 1 10.1186/1478-7547-6-1 18190684 (Pubitemid 351418914)
29. Chronic disease projections in heterogeneous ageing populations: approximating multi-state models of joint distributions by modelling marginal distributions. Hoogenveen RT, van Baal PHM, Boshuizen HC, Math Med Biol 2010 27 1 19 10.1093/imammb/dqp014 19516046
30. Translation, validation, and norming of the Dutch language version of the SF-36 Health Survey in community and chronic disease populations. Aaronson NK, Muller M, Cohen PD, Essink-Bot ML, Fekkes M, Sanderman R, Sprangers MA, te Velde A, Verrips E, J Clin Epidemiol 1998 51 1055 1068 10.1016/S0895-4356(98)00097-3 9817123 (Pubitemid 28527161)
31. EuroQol: the current state of play. Brooks R, Health Policy 1996 37 53 72 10.1016/0168-8510(96)00822-6 10158943 (Pubitemid 26191458)
32. Kwaliteit van leven meten in economische evaluaties: het Nederlands. Lamers LM, Stalmeier PFM, Mcdonnell J, Van Busschbach PFMKJJ, Ned Tijdschr Geneeskd 2005 149 1574 1578 16038162 (Pubitemid 40978328)
33. Bouwmans C, Hakkaart-van Roijen L, Koopmanschap M, Krol M, Severens H, Brouwer W, Handleiding iMTA Productivity Cost Questionnaire (iPCQ) Rotterdam: iMTA, Erasmus Universiteit 2013
34. van RL H, Tan S, Bouwmans C, Handleiding Voor Kostenonderzoek-Methoden En Standaard Kostprijzen Voor Economische Evaluaties in de Gezondheidszorg Rotterdam: MTA, Erasmus Universiteit 2010
35. STIVORO, Kerncijfers Roken in Nederland 2011. Een Overzicht van Recente Nederlandse Basisgegevens over Rookgedrag Den Haag: STIVORO 2012
36. Cost-effectiveness of face-to-face smoking cessation interventions: a dynamic modeling study. Feenstra TL, Hamberg-van Reenen HH, Hoogenveen RT, Rutten-van Mölken MPMH, Value Health 2005 8 178 190 10.1111/j.1524-4733. 2005.04008.x 15877590 (Pubitemid 41023477)
37. Van Baal PHM, Feenstra TL, Hoogenveen RT, Wit GA D, Cost Effectiveness Analysis with the RIVM Chronic Disease Model. Report No. 260706002 Bilthoven: Rijksinstituut voor Volksgezondheid en Milieu 2005 1 27
38. Cost-effectiveness of lifestyle modification in diabetic patients. Jacobs-van der Bruggen M, van Baal P, Hoogenveen RT, Feenstra T, Briggs A, Lawson K, Feskens E, Baan C, Diabetes Care 2009 32 1453 1458 10.2337/dc09-0363 19435958
39. Non-participants in a preventive health examination for cardiovascular disease: characteristics, reasons for non-participation, and willingness to participate in the future. Wall M, Teeland L, Scand J Prim Health Care 2004 22 248 251 10.1080/02813430410006611 15765642 (Pubitemid 39601988)